Biocompatibility of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation

Microspheres have been prepared from the resorbable linear polyester of β-hydroxybutyric acid (polyhydroxybutyrate, PHB) by the solvent evaporation technique and investigated in vitro and in vivo. Biocompatibility of the microspheres has been proved in tests in the culture of mouse fibroblast cell line NIH 3T3 and in experiments on intramuscular implantation of the microspheres to Wistar rats for 3 months. Tissue response to the implantation of polymeric microspheres has been found to consist in a mild inflammatory reaction, pronounced macrophage infiltration that increases over time, involving mono- and poly-nuclear foreign body giant cells that resorb the polymeric matrix. No fibrous capsules were formed around polymeric microparticles; neither necrosis nor any other adverse morphological changes and tissue transformation in response to the implantation of the PHB microparticles were recorded. The results of the study suggest that polyhydroxybutyrate is a good candidate for fabricating prolonged-action drugs in the form of microparticles intended for intramuscular injection.

[1]  S. Feng,et al.  Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. , 2003, Biomaterials.

[2]  J M Anderson,et al.  In vivo biocompatibility studies. I. The cage implant system and a biodegradable hydrogel. , 1983, Journal of biomedical materials research.

[3]  F J Schoen,et al.  Tissue engineering of heart valves: in vitro experiences. , 2000, The Annals of thoracic surgery.

[4]  T. Volova,et al.  Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood , 2003, Journal of biomaterials science. Polymer edition.

[5]  Weiliam Chen,et al.  Hyaluronan microspheres for sustained gene delivery and site-specific targeting. , 2004, Biomaterials.

[6]  S. Harrison,et al.  Plasticization of poly(hydroxybutyrate) in vivo. , 1992, International journal of biological macromolecules.

[7]  T. G. Volova,et al.  A comparative investigation of biodegradable polyhydroxyalkanoate films as matrices for in vitro cell cultures , 2004, Journal of materials science. Materials in medicine.

[8]  A. Hiltner,et al.  Theoretical analysis of in vivo macrophage adhesion and foreign body giant cell formation on polydimethylsiloxane, low density polyethylene, and polyetherurethanes. , 1994, Journal of biomedical materials research.

[9]  S. Hesseling,et al.  Biocompatibility and degradation of poly(ether-ester) microspheres: in vitro and in vivo evaluation. , 2002, Biomaterials.

[10]  R Langer,et al.  Responsive polymeric delivery systems. , 2001, Advanced drug delivery reviews.

[11]  R. Ian Freshney,et al.  Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications , 2010 .

[12]  A. Hiltner,et al.  Creep of a poly(etherurethane urea) in an oxidative environment. , 1994, Journal of biomedical materials research.

[13]  D E H Tee,et al.  Book Review: Culture of Animal Cells: A Manual of Basic Technique , 1984 .

[14]  F. Korkusuz,et al.  In vivo response to biodegradable controlled antibiotic release systems. , 2001, Journal of biomedical materials research.

[15]  J. Breitenbach Melt extrusion: from process to drug delivery technology. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  T. Volova,et al.  Degradation of P(3HB) and P(3HB-co-3HV) in biological media , 2005, Journal of biomaterials science. Polymer edition.

[17]  M. Simeonova,et al.  Study of the effect of polybutylcyanoacrylate nanoparticles and their metabolites on the primary immune response in mice to sheep red blood cells. , 1998, Biomaterials.

[18]  Qiong Wu,et al.  In vivo studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) based polymers: biodegradation and tissue reactions. , 2006, Biomaterials.

[19]  P. Neuenschwander,et al.  In vitro evaluation of the biofunctionality of osteoblasts cultured on DegraPol-foam , 2000, Journal of biomaterials science. Polymer edition.

[20]  David P. Martin,et al.  PHA applications: addressing the price performance issue: I. Tissue engineering. , 1999, International journal of biological macromolecules.

[21]  Yasuhiko Tabata,et al.  Polyhydroxyalkanonate derivatives in current clinical applications and trials. , 2003, Advanced drug delivery reviews.

[22]  Holly M. Brown-Borg,et al.  Culture of Animal Cells: A Manual of Basic Technique, R. Ian Freshney (Ed.). Wiley-Liss, Inc., New York (1994) , 1995 .

[23]  X. Zhu,et al.  Polymer microspheres for controlled drug release. , 2004, International journal of pharmaceutics.

[24]  J M Anderson,et al.  Inflammatory response to implants. , 1988, ASAIO transactions.

[25]  A. Hiltner,et al.  Theoretical analysis of in vivo macrophage adhesion and foreign body giant cell formation on strained poly(etherurethane urea) elastomers. , 1994, Journal of biomedical materials research.

[26]  J. Benoit,et al.  The brain tissue response to biodegradable poly(methylidene malonate 2.1.2)-based microspheres in the rat. , 2006, Biomaterials.

[27]  T G Volova,et al.  Tissue response to the implantation of biodegradable polyhydroxyalkanoate sutures , 2004, Journal of materials science. Materials in medicine.

[28]  F J Schoen,et al.  Tissue-engineered valved conduits in the pulmonary circulation. , 2000, The Journal of thoracic and cardiovascular surgery.

[29]  S. Perren,et al.  Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). , 1993, Journal of biomedical materials research.

[30]  Jagdish Singh,et al.  Preparation, in vitro release, in vivo absorption and biocompatibility studies of insulin-loaded microspheres in rabbits , 2005, AAPS PharmSciTech.

[31]  K.H.J. Buschow,et al.  Encyclopedia of Materials: Science and Technology , 2004 .

[32]  A. Fiszer-Kierzkowska,et al.  Oligo-3-hydroxybutyrates as potential carriers for drug delivery. , 2004, Biomaterials.

[33]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[34]  H. Yang,et al.  Long-acting delivery microspheres of levo-norgestrol-poly(3-hydroxybutyrate): their preparation, characterization and contraceptive tests on mice. , 2001, Journal of microencapsulation.

[35]  Brian J. Tighe,et al.  A review of biodegradable polymers: uses, current developments in the synthesis and characterization of biodegradable polyesters, blends of biodegradable polymers and recent advances in biodegradation studies , 1998 .

[36]  J M Anderson,et al.  Theoretical analysis on cell size distribution and kinetics of foreign-body giant cell formation in vivo on polyurethane elastomers. , 1992, Journal of biomedical materials research.

[37]  V. Hasırcı,et al.  Properties and drug release behaviour of poly(3-hydroxybutyric acid) and various poly(3-hydroxybutyrate-hydroxyvalerate) copolymer microcapsules. , 1995, Journal of microencapsulation.

[38]  F. Korkusuz,et al.  In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. , 2001, Biomaterials.

[39]  K. Öğe,et al.  Tramadol encapsulated into polyhydroxybutyrate microspheres: in vitro release and epidural analgesic effect in rats , 2003, Acta anaesthesiologica Scandinavica.

[40]  Colin W. Pouton,et al.  Biosynthetic polyhydroxyalkanoates and their potential in drug delivery , 1996 .